الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 164 |  |  |
| | | from | 164 | | |
Abstract
Obesity affects people of all ages in all countries. Obesity affects both physical and emotional health and if untreated, obesity increases the risk of developing numerous health complications.
The BMI growth curves define a child in the 85th to 94th percentile range as overweight, whereas a child in the greater than 95th percentile is defined as obese.
The aim of the work in this study is to assess the efficacy, feasibility and safety of laparoscopic sleeve gastrectomy in obese pediatric patients and Assessment of the LSG on the growth of pediatric patients.
This study had been conducted on 15 pediatric patients with morbid obesity with a mean age of 13±1.41 years. The patients include 8 male patients (53.3%) and 7 female patients (46.7%). The mean BMI of our patients is 51.33±10.77 Kg/m2, the mean operative time is 48.67±5.5 minutes, the mean hospital stay duration of 2.93±1.53 days. In this study 7 patients (46.7%) had co-morbidities and 8 patients (53.3%) had no co-morbidities.
The percentage of the EWL in our patients ranged between 31.8 and 95 % with a mean of 77.37±18.56. The BMI after one year were ranged between 22.8 and 55.4 Kg/m2 with a mean of 29.5±8.29 Kg/m2. The follow up of our patients after 1 year on the BMI growth curves revealed that they ranged between 85th & 99th percentile with the mean of 92.8±4.29th percentile.
In our study the mean preoperative height was 154.73±19.16 cm and the mean one year post operative was 160.47±19.03 cm. These patients gained a mean of 5.6±0.13 cm in one year. We had one complication (6.67%) in the form of post operative bleeding for her conservative management was done and there was no surgical intervention and there is no mortality.
Conclusion:
In conclusion, the LSG in pediatric patients with morbid obesity results in effective weight loss and resolution of co-morbidity in the short to medium term and is promising for the long-term management of morbid obesity in pediatric patients. This indicates that, considering the acceptable complication rate, surgical intervention is feasible and safe in appropriately selected patients.
The growth of the pediatric patients with morbid obesity is not affected after LSG.
Long-term follow up of our patients is needed to assess and evaluate the progress of the growth and evaluation of weight loss and if there is any relapses.
Another studies are needed for trials of other modalities of bariatric surgery in pediatric patients and if it is safe and feasible or not.